share_log

Wolverine Asset Management LLC Grows Stock Holdings in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDU)

Wolverine Asset Management LLC Grows Stock Holdings in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDU)

金剛狼資產管理公司增持智能醫藥收購公司(納斯達克代碼：IQMDU)
Defense World ·  2022/11/03 06:02

Wolverine Asset Management LLC grew its holdings in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDU – Get Rating) by 107.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 5,977 shares of the company's stock after purchasing an additional 3,089 shares during the period. Wolverine Asset Management LLC's holdings in Intelligent Medicine Acquisition were worth $60,000 as of its most recent SEC filing.

金剛狼資產管理有限公司(Wolverine Asset Management LLC)根據其最近向美國證券交易委員會披露的數據，第二季度增持了智能醫藥收購公司(Johnson：IQMDU-GET Rating)的股票，增幅為107.0%。該基金持有5977股該公司股票，在此期間又購買了3,089股。截至最近提交給美國證券交易委員會的文件，金剛狼資產管理有限公司在智能醫藥收購中持有的股份價值60,000美元。

Separately, Spartan Fund Management Inc. bought a new stake in shares of Intelligent Medicine Acquisition during the first quarter valued at approximately $1,264,000.

另外，斯巴達基金管理公司(Spartan Fund Management Inc.)在第一季度購買了智能醫藥收購公司的新股，價值約1,264,000美元。

Get
到達
Intelligent Medicine Acquisition
智能醫療採集
alerts:
警報：

Intelligent Medicine Acquisition Price Performance

智能醫療採辦性價比

Shares of IQMDU opened at $10.13 on Thursday. The firm has a 50 day moving average of $10.09 and a 200 day moving average of $10.08. Intelligent Medicine Acquisition Corp. has a twelve month low of $9.94 and a twelve month high of $10.30.

週四，IQMDU的股價開盤報10.13美元。該公司的50日移動均線切入位在10.09美元，200日移動均線切入位在10.08美元。智能醫藥收購公司的股價為9.94美元的12個月低點和10.30美元的12個月高位。

About Intelligent Medicine Acquisition

關於智能醫療採辦

(Get Rating)
(獲取評級)

Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.

智能醫藥收購公司沒有重大業務。公司專注於與一家或多家企業進行合併、資本換股、資產收購、股票購買、重組或相關業務合併。它打算確定生命科學領域的商業機會。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMDU)
  • New Revenue Strategy, Strong Earnings, Apple Remains a Buy
  • Devon Energy Lower After Beating Q3 Views But Slashing Dividend
  • Chesapeake Energy Focus on Natural Gas Leads to Strong Results
  • Are Investors Bailing on Travel America as Diesel Shortages Loom?
  • Sell-Side Interest Drives Mondelez Higher
  • 免費獲取StockNews.com關於智能醫療獲取的研究報告(IQMDU)
  • 新的收入戰略，強勁的收益，蘋果仍然是一個買入者
  • Devon Energy股價下跌，此前第三季度業績好於預期，但大幅削減股息
  • 切薩皮克能源專注於天然氣帶來強勁業績
  • 柴油短缺迫在眉睫，投資者是否放棄了美國之旅？
  • 賣方興趣推動Mondelez走高

Want to see what other hedge funds are holding IQMDU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDU – Get Rating).

想看看還有哪些對衝基金持有IQMDU嗎？訪問HoldingsChannel.com獲取智能醫藥收購公司(納斯達克：IQMDU-GET Rating)的最新13F備案文件和內幕交易信息。

Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

接受《智能醫藥採購日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對智能醫藥收購和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論